demo fortune gems

It was a long and mostly miserable season for Toronto’s veteran reliever Jordan Romano in 2024. He was coming off two All-Star seasons as the Blue Jays closer, had accumulated 95 saves over the previous three seasons, but but as the season trickled through the late spring it became obvious this season wasn’t going to turn out like those other two. He first encountered elbow inflammation issues during spring training, delaying his season start until mid-April. He seemed to pick up where he’d left off in 2023, accumulating four saves in a couple of weeks, but his velocity dropped significantly during a stretch in May and his ERA ballooned to 6.59 before he was finally pulled from action at the end of the month. But before his injury troubles really began to set in on him, there was the memory of the day that he managed his fifth save of the season, coming on May 8 on the road in a day game at Citizens Bank Park. “The place was absolutely sold out,” Romano said Tuesday, recalling the surprise of what even a workday baseball game in South Philadelphia was like. “The atmosphere was electric, and kind of coming off that series, I thought that if I get a chance to play here, I think I’d really enjoy it.” Romano will indeed get that chance, after he was signed Monday to a one-year, $8.5 million contract by Phillies president Dave Dombrowski. While some critics thought the signing was a bit of a gamble with what today is almost like a pocket-change free agent contract, Dombrowski sees in Romano a 31-year-old premier reliever almost back to full health and still in the prime of his career. Before departing the Winter Meetings in Dallas, Dombrowski praised Romano, calling him “one of the best back-end, high-leverage guys in baseball. Our medicals on him have been very good.” On a Zoom call with media members Tuesday, Romano said he was excited to keep progressing in his efforts to recapture his form from a couple of seasons ago. “Last Friday I got off the mound, felt great, mid-90s, for the first bullpen, which i was really excited about,” said Romano. He added that after another few weeks of “deloading” and strength training, he’ll get back to throwing bullpens in January. But he thinks he’s well on his way to full recovery before spring training starts. It was a long road. Romano, 31, would go on IL on June 1, and after another setback during rehab finally underwent elbow surgery in July. His rehab after that didn’t go well, either, and after initial optimism that he’d be returning sometime in August, the call was made to let him continue to rehab while the Blue Jays were quickly playing themselves out of contention. “The whole plan last year was never really to come back at the end of the year. We were just going to take it a little bit ... not even slower, just follow the timeline with that,” said Romano, a native of Markham, Ontario. “I want to get back on track, I’m feeling healthy and good now so I just want to have the one year to get back out there and prove my worth.” Before meeting any of his teammates, Romano can feel comfortable knowing that his manager, Rob Thomson, is a fellow Ontarian. But Thomson isn’t being provincial in his thinking about Romano’s role here – there were no fast promises of giving a closer role to Romano. Thomson doesn’t like to use that “closer” term anyway. Instead, the plan for Romano is to help in “high-leverage” situations, especially since both Jeff Hoffman and Carlos Estevez are currently on the free agency market themselves. The Phillies now have Romano to go with fellow right-hander Orion Kerkering and left-handers Matt Strahm and Jose Alvarado as back-end bullpen weapons. “I’m just kind of going in and wherever I can, help,” Romano said. “If they want me to throw the ninth, you know, I do love closing. I have experience there and I’m happy to do it. But if they need me in other spots, too, I’m happy to do that. “I’m kind of just there to help get big outs wherever they need them.”Nonedemo fortune gems 。

NASA's 2 stuck astronauts face more time in space with return delayed until at least late March

Inspire Corporate Bond ETF ( NYSEARCA:IBD – Get Free Report )’s stock price fell 0.2% during mid-day trading on Friday . The stock traded as low as $23.42 and last traded at $23.44. 20,244 shares changed hands during trading, a decline of 75% from the average session volume of 82,560 shares. The stock had previously closed at $23.48. Inspire Corporate Bond ETF Stock Performance The firm has a 50 day moving average of $23.67 and a 200-day moving average of $23.76. Hedge Funds Weigh In On Inspire Corporate Bond ETF Institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC boosted its stake in Inspire Corporate Bond ETF by 343.7% during the second quarter. EverSource Wealth Advisors LLC now owns 49,029 shares of the company’s stock valued at $1,160,000 after buying an additional 37,979 shares during the last quarter. Vicus Capital raised its holdings in shares of Inspire Corporate Bond ETF by 12.3% during the 3rd quarter. Vicus Capital now owns 69,130 shares of the company’s stock worth $1,665,000 after acquiring an additional 7,577 shares in the last quarter. Creative Financial Designs Inc. ADV boosted its position in shares of Inspire Corporate Bond ETF by 20.3% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 667,785 shares of the company’s stock valued at $16,080,000 after acquiring an additional 112,635 shares during the last quarter. Finally, JPMorgan Chase & Co. purchased a new position in shares of Inspire Corporate Bond ETF in the third quarter valued at $1,611,000. Inspire Corporate Bond ETF Company Profile The Inspire Corporate Bond Impact ESG ETF (IBD) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks an equally weighted index of bonds issued by S&P 500-component companies that meet biblically responsible investing standards according to the Issuer. IBD was launched on Jul 10, 2017 and is managed by Inspire. Recommended Stories Receive News & Ratings for Inspire Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter .How co-writing a book threatened the Carters' marriageBrian Thompson, the CEO of UnitedHealthcare, who was fatally shot in Midtown Manhattan on Wednesday in what New York police called a "brazen, targeted attack," was a longtime leader in Corporate America, a model student and star high school athlete – and he had been caught up in a high-profile insider trading lawsuit this year. Thompson, 50, lived in Minnesota and was visiting New York for UnitedHealthcare's annual investors conference before he was killed. Thompson was appointed chief executive of UnitedHealthcare in 2021, and had been at the company since 2004. Prior to being named chief executive of UnitedHealthcare, Thompson worked as CEO of the company's government programs business, which includes its Medicare and retirement businesses. UnitedHealthcare is part of UnitedHealth Group, America's largest insurance company. Prior to joining UnitedHealthcare in 2004, Thompson worked as a manager and practiced as a CPA at PwC for nearly seven years. Thompson graduated from the University of Iowa in 1997 with a bachelor's degree in business administration with a major in accounting. He graduated as valedictorian, according to his LinkedIn. He was a Collegiate Scholar, Carver Scholar, State of Iowa Scholar and Faculty Scholar. Thompson graduated from South Hamilton High School in Jewell, Iowa, in 1993. Thompson was the valedictorian of his class, Heather Holm, the superintendent for South Hamilton Community School District, told CNN. "During his time at South Hamilton, Brian was a star student, athlete, homecoming king, and a respected leader. His achievements and character left a meaningful legacy within our schools and community," Holm said in a statement. "We join all who are mourning in remembering Brian's life and legacy." Thompson is remembered as a beloved leader and friend, according to UnitedHealth Group. "Brian was a highly respected colleague and friend to all who worked with him," the company said in a statement. Thompson in May was sued for alleged fraud and illegal insider trading. The Hollywood Firefighters' Pension Fund filed a lawsuit against UnitedHealth Group, CEO Andrew Witty, Executive Chairman Stephen Hemsley and Thompson, alleging the executives schemed to inflate the company's stock by failing to disclose a U.S. Justice Department antitrust investigation into the company. UnitedHealth Group in 2021 announced it would buy Change Healthcare. The Justice Department sued to break up the deal but a judge ultimately allowed it go through. But the Wall Street Journal in February 2024 reported the Department of Justice re-opened its case, even after the merger went through, to investigate whether the companies properly set up a so-called firewall to prevent customer information from flowing between divisions of the merged company. The lawsuit claimed Thompson knew about the investigation as early as October 2023 and sold 31% of his company shares, making a $15 million profit, 11 days before the Journal publicized the probe. The Journal report sent UnitedHealth's stock sinking 5%. The revelation of the alleged insider trading led Democratic Sens. Elizabeth Warren and Ed Markey to write a letter to the Securities and Exchange Commission on April 29, calling on Chairman Gary Gensler to investigate UnitedHealth for the executives' stock sales. The senators noted Thompson faced up to $5 million in penalties and 20 years of prison time if convicted. "The reports regarding these trades reveal a disturbing fact pattern," the senators wrote. "The timing of these trades... raises numerous questions." The lawsuit, which remains active, was seeking a jury trial and unspecified damages from UnitedHealth and the executives named in the suit, including Thompson. The Southern District of New York declined to comment. UnitedHealthcare did not respond to a request for comment on the lawsuit. CNN's Kara Scannell contributed to this report.10-man Barcelona concedes two late goals in draw at Celta Vigo